基本信息
浏览量:292
职业迁徙
个人简介
Experiments in this laboratory and elsewhere have established the existence in adults (both mouse and man) of primitive hematopoietic stem cells capable of permanently reconstituting the production of mature blood cells in marrow-ablated or suppressed recipients. A major part of our work continues to focus on the development, validation and use of quantitative assays that are specific for biologically distinct subsets of these stem cells using syngeneic (mouse-mouse) and xenogeneic (human-mouse) hosts. From large sets of in vitro and in vivo experiments of clonally monitored responses of individual highly purified stem cells, we have recently discovered two sources of their heterogeneous behaviour. One is determined by the complement of externally-derived signals to which the stem cells are exposed. The second appears to be intrinsically determined leading to a differentiation behaviour that can be passed on with fidelity through many stem cell divisions. We have also identified a developmental “switch” that alters stem cell proliferation and self-renewal control in the post-natal period. We are now trying to elucidate the molecular mechanisms underlying each of these causes of variable stem cell behaviour using defined culture systems, gene transfer strategies, and genome-wide gene expression analyses.
Another goal is to investigate the molecular basis of the altered behaviour of the leukemic stem cells in patients with chronic myeloid leukemia, to develop new models of this disease in mice reconstituted with genetically modified human and murine stem cells and to identify new agents for their selective kill.
A third initiative is focused on extending the above approaches to the study of human breast cancer. We have pioneered the development of quantitative assays for normal mouse and human breast epithelial stem cells and these are being used to identify their distinguishing features and growth regulation. Studies to adapt these methods for application to human breast cancer are underway. The objective is to provide a basis for analyzing molecular and genetic determinants of breast cancer at the level of the breast cancer stem cell and thereby develop more rational, patient-targeted therapies.
Another goal is to investigate the molecular basis of the altered behaviour of the leukemic stem cells in patients with chronic myeloid leukemia, to develop new models of this disease in mice reconstituted with genetically modified human and murine stem cells and to identify new agents for their selective kill.
A third initiative is focused on extending the above approaches to the study of human breast cancer. We have pioneered the development of quantitative assays for normal mouse and human breast epithelial stem cells and these are being used to identify their distinguishing features and growth regulation. Studies to adapt these methods for application to human breast cancer are underway. The objective is to provide a basis for analyzing molecular and genetic determinants of breast cancer at the level of the breast cancer stem cell and thereby develop more rational, patient-targeted therapies.
研究兴趣
论文共 812 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Ebrahim Eskandari,Gian Luca Negri,Susanna Tan,Margarita E. MacAldaz, Shengsen Ding, Justin Long, Karina Nielsen,Sandra E. Spencer,Gregg B. Morin,Connie J. Eaves
Cell Death Discoveryno. 1 (2024): 1-9
BLOODno. 16 (2023): 1990-2002
Experimental hematology (2023): 1-1
J. Ng, Kui‐Thong Tan, D. Guo,Joey Jia Hui Lai, Xianqun Fan,Zhiyong Poon,Tse Hui Lim,Alvin Soon Tiong Lim,Kiat Hon Lim,William Ying Khee Hwang,Shang Li,Connie J. Eaves,
Science Advancesno. 24 (2023)
引用0浏览0引用
0
0
Experimental Hematology (2023): S109-S109
crossref(2023)
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn